Global Cloning & Mutagenesis Market Report 2023: Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fuels Growth
18 avr. 2023 11h58 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Gene Type (Standard v/s...
United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update
14 avr. 2023 07h33 HE
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ...
Exosome Therapeutics Global Market Report 2023: Multifunctional Properties for the Treatment of Cancer, Alzheimer's, Parkinson's and Heart Failure Drives Adoption
13 avr. 2023 06h43 HE
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Exosome Type (Natural v/s...
Global Epigenetics Market Report 2023: Rising Prevalence of Cancer and Other Diseases Drives Growth
12 avr. 2023 11h48 HE
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
05 avr. 2023 03h00 HE
|
SiSaf Ltd
GUILDFORD, England, April 05, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announced that it has appointed Dr. Richard Goodfellow to its Board of Directors. ...
Global RNA Analysis/Transcriptomics Market Report 2023: Increasing Demand for Personalized Medicine is Expected to Drive Growth
31 mars 2023 07h53 HE
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "RNA Analysis/Transcriptomics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
30 mars 2023 16h05 HE
|
GreenLight Biosciences
BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to...
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
28 mars 2023 17h05 HE
|
GreenLight Biosciences
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical...
Global Human Identification Market to 2027: Rising Adoption of Forensic Applications Fuels Growth
14 mars 2023 13h13 HE
|
Research and Markets
Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Human Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Application, By End...
Ractigen Therapeutics Receives FDA Orphan Drug Designation for the novel oligonucleotide conjugate RAG-17 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
03 mars 2023 09h00 HE
|
Ractigen Therapeutics
JIANGSU, China, March 03, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to RAG-17, a novel siRNA...